Tirzepatide targets both the GIP (Glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, enhancing insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control
Cardiometabolic Improvements Beyond total weight loss, the study documented impressive improvements in cardiometabolic parameters: substantial reductions in waist circumference
The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
"Due to the complexity in detection of Cyclospora, FDA laboratory experts re-reviewed the sample results and have concluded that the finding does not represent true amplification and should be considered a false positive," the agency said in a statement
Skin laxity can be a concern as we age or lose weight from GLP-1s (like Ozempic)
What are the risks of using unapproved peptides